JNJ
Johnson & Johnson
NYSE: JNJ · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$229.85
+1.10% today
Updated 2026-04-30
Market cap
$547.28B
P/E ratio
26.31
P/S ratio
5.68x
EPS (TTM)
$8.64
Dividend yield
2.28%
52W range
$142 – $252
Volume
8.0M
Johnson & Johnson (JNJ) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $70.56B | $80.95B | $84.91B | $94.68B | $102.91B | $113.64B | $121.35B | $132.68B | $130.36B | $133.41B | $141.21B | $157.30B | $152.95B | $157.73B | $174.89B | $182.02B | $187.38B | $167.56B | $180.10B | $199.21B |
| Cash & equivalents | $4.08B | $7.77B | $10.77B | $15.81B | $19.36B | $24.54B | $14.91B | $20.93B | $14.52B | $13.73B | $18.97B | $17.82B | $18.11B | $17.30B | $13.98B | $14.49B | $12.89B | $21.86B | $24.11B | $19.71B |
| Current assets | $22.98B | $29.95B | $34.38B | $39.54B | $47.31B | $54.32B | $46.12B | $56.41B | $59.31B | $60.21B | $65.03B | $43.09B | $46.03B | $45.27B | $51.24B | $60.98B | $55.29B | $53.49B | $55.89B | $55.62B |
| Total liabilities | $31.24B | $37.63B | $42.40B | $44.09B | $46.33B | $56.56B | $56.52B | $58.63B | $61.37B | $62.26B | $70.79B | $97.14B | $93.20B | $98.26B | $111.62B | $108.00B | $110.57B | $98.78B | $108.61B | $117.67B |
| Current liabilities | $19.16B | $19.84B | $20.85B | $21.73B | $23.07B | $22.81B | $24.26B | $25.68B | $25.09B | $27.75B | $26.29B | $30.54B | $31.23B | $35.96B | $42.49B | $45.23B | $55.80B | $46.28B | $50.32B | $54.13B |
| Long-term debt | $2.01B | $7.07B | $8.12B | $8.22B | $9.16B | $12.97B | $11.49B | $13.33B | $15.12B | $12.86B | $22.44B | $30.68B | $27.68B | $26.49B | $32.63B | $29.98B | $26.89B | $25.88B | $30.65B | $39.44B |
| Shareholder equity | $39.32B | $43.32B | $42.51B | $50.59B | $56.58B | $57.08B | $64.83B | $74.05B | $69.75B | $71.15B | $70.42B | $60.16B | $59.75B | $59.47B | $63.28B | $74.02B | $76.80B | $68.77B | $71.49B | $81.54B |
| Retained earnings | $49.29B | $55.28B | $63.38B | $70.31B | $77.77B | $81.25B | $85.99B | $89.49B | $97.25B | $103.88B | $110.55B | $101.79B | $106.22B | $110.66B | $113.89B | $123.06B | $128.34B | $153.84B | $155.79B | $168.98B |
| Accounts receivable | $8.71B | $9.44B | $9.72B | $9.65B | $9.77B | $10.58B | $11.31B | $11.71B | $10.98B | $10.73B | $11.70B | $13.49B | $14.10B | $14.48B | $13.58B | $18.98B | $16.91B | $14.87B | $18.93B | $17.18B |
| Inventory | $4.89B | $5.11B | $5.05B | $5.18B | $5.38B | $6.29B | $7.50B | $7.88B | $8.18B | $8.05B | $8.14B | $8.77B | $8.60B | $9.02B | $9.34B | $10.39B | $10.27B | $11.18B | $12.44B | $14.19B |
| Goodwill | $13.34B | $14.12B | $13.72B | $14.86B | $15.29B | $16.14B | $22.42B | $22.80B | $21.83B | $21.63B | $22.80B | $31.91B | $30.45B | $33.64B | $36.39B | $35.25B | $36.05B | $36.56B | $44.20B | $48.77B |